News |
Press Releases News Coverage
Investors
CONTACT US

Rafael Holdings

Navigation
  • Rafael Pharmaceuticals
  • Real Estate Holdings
  • Lipomedix Pharmaceuticals
  • Leadership
    • Board of Directors
    • Executive Management
  • Rafael Pharmaceuticals
  • Real Estate Holdings
  • Lipomedix Pharmaceuticals
  • Leadership
    • Board of Directors
    • Executive Management
Investors

Investors

 
Click to expand/collapse Aug 05, 2019
Click to open news item in new windowNews from LipoMedix: LipoMedix Appoints New Members to Board of Directors and Creates New Executive Committee

Click to expand/collapse Apr 13, 2018
Click to open news item in new windowPress Release from Rafael Pharmaceuticals: Clinical Cancer Research Publishes Phase I Data from a Study of Rafael Pharmaceuticals' Lead CPI-613 Compound in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

 1   2   3     4   
 <<   <   >   >> 
  • Real Estate Holdings
  • Rafael Pharmaceuticals
  • Lipomedix Pharmaceuticals
  • Leadership
  • Press Releases
  • News Coverage
  • Investors
  • Contact Us
  • Privacy Policy
  • Disclaimer

Copyright © Rafael Holdings, Inc. All rights reserved


Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window